Loading...

4,068 posters, 219 videos, 101 topics, 69 sessions, 14,365 authors, 6,128 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

Alzheimer's Association International Conference 2026

July 12-15, 2026 | London, United Kingdom, and Online

Alzheimer's Association International Conference 2026 banner

262

Machine Learning's Diagnostic Performance Of Cognitive Decline Via Handwriting: A Systematic Review And Meta-analysis

Part of Topic

Title: Machine Learning's Diagnostic Performance Of Cognitive Decline Via Handwriting: A Systematic Review And Meta-analysis


Author Block: 
Ching-Wei Ye1, Chien-Liang Liu2, Fu-Ling Yang3, Nga-Weng Ieong4, Shu-Wei Chang5, Tien-Ni Wang1, Hao-Ling Chen1,6.
1School of Occupational Therapy, National Taiwan University, College of Medicine, Taipei City, Taiwan, 
2Department of Neurology, Taipei City Hospital, Taipei City, Taiwan, 
3School of Nursing, National Taiwan University, College of Medicine, Taipei City, Taiwan, 
4Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei City, Taiwan, 
5Department of Civil Engineering, National Taiwan University, Taipei City, Taiwan, 
6Health Science and Wellness Center, National Taiwan University, Taipei City, Taiwan.


Introduction: 

Cognitive decline—from mild cognitive impairment (MCI) to Alzheimer’s disease (AD)
—is a growing global health burden, yet neuroimaging and cerebrospinal fluid biomarkers are costly, invasive, and inaccessible in primary care.

Handwriting integrates fine motor control, visuospatial attention, and cognitive processing;
its kinematics (velocity, in-air time, fluency) are a promising non-invasive digital biomarker.

Machine learning (ML) enables automated HC / MCI / AD classification,
but reported accuracy varies widely. We synthesized the evidence and identified the methodological factors that drive diagnostic performance.


Methods: 

PRISMA-guided systematic review; PubMed & Cochrane Library (2004–2024), English only; 18 studies included.
Population: adults ≥60 with AD, MCI, or healthy controls (HC);
Index test: ML on digitized handwriting or drawing;
Reference: established clinical or neuropsychological criteria.
The risk of bias was assessed using the QUADAS-2.
The 2×2 confusion matrices were extracted or reconstructed for each study (TP/FP/TN/FN).
Bivariate random-effects meta-analysis; HSROC curves; meta-regression on handwriting task type, ML algorithm category.


Results: 
Common handwriting features:
mean/peak velocity, motor quality index (velocity peaks, jerks), pressure variability, pen-in-air time.

Pooled Diagnostic Accuracy:
Fig A. HC vs. AD (16 studies): sensitivity 88.1% (83.9–91.3), specificity 90.9% (86.8–93.7), AUC 0.947.
Fig B. HC vs. MCI (11 studies): sensitivity 77.8% (69.2–84.6), specificity 76.8% (71.1–81.1), AUC 0.83.

Meta-regression: task type and ML algorithm significantly drove heterogeneity.
Combining multiple tasks with ensemble or deep learning models achieved the highest accuracy.


Conclusion: 

Handwriting kinematics are promising behavioral markers for screening AD and MCI.

Combined writing-and-drawing protocols with ensemble or deep-learning models give the best diagnostic performance.

Trade-off: multi-task batteries raise patient burden; community screening may favor optimized single tasks.

Suggestion: explainable AI (XAI), early pre-symptomatic MCI detection, standardized multi-center datasets.

Future Work: include 2025-2026’s studies, identify the optimal single handwriting task,
and examine the smallest feature amount required to achieve high accuracy through further meta-regression.

Comments

Email is required but is not shown publicly.

Loading comments...

aaic2026 banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.